Alicia BergClinical Trial Transparency Strategy Lead at BiogenSpeaker
Profile
Alicia Berg is a former Scientific Officer of the EMA. She worked on Policy 0070 and Policy 0043 linked to clinical data publication and data disclosure related to the life-cycle and approval of medicinal products in the EU&EEA. Previously she fulfilled clinical operations roles in clinical trial management and expanded access to deliver treatment for patients with unmet clinical needs.
Agenda Sessions
Is the disclosure of data truly beneficial for patients?
, 3:30pmView Session